Caris Life Sciences, Inc.(CAI US)
$32.00+0.290.91%Ext:$30.63-1.384.30%(Market Closed · 23:53:13 UTC)
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY200312/31/2003 | FY200412/31/2004 | FY200512/31/2005 | FY200612/31/2006 | FY200712/31/2007 | FY200812/31/2008 | FY200912/31/2009 | FY201012/31/2010 | FY201112/31/2011 | FY201212/31/2012 | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 56.4 | 64.0 | 797.8 | 821.1 | |||||||||||||||||||||
| Short Term Investments | 65.2 | 2.2 | 2.3 | 2.3 | |||||||||||||||||||||
| Cash and Short Term Investments | 121.6 | 66.2 | 800.1 | 823.5 | |||||||||||||||||||||
| Net Receivables | 55.3 | 88.2 | 112.1 | 90.5 | |||||||||||||||||||||
| Inventory | 49.0 | 39.6 | - | - | |||||||||||||||||||||
| Other Current Assets | 5.0 | 8.2 | 85.6 | 100.2 | |||||||||||||||||||||
| Total Current Assets | 242.6 | 215.7 | 997.8 | 1,014.2 | |||||||||||||||||||||
| Property, Plant & Equipment | 147.5 | 102.8 | 63.2 | 82.7 | |||||||||||||||||||||
| Long Term Investments | - | - | - | - | |||||||||||||||||||||
| Other Non-Current Assets | 3.4 | 5.9 | 45.3 | 46.2 | |||||||||||||||||||||
| Total Non-Current Assets | 170.3 | 128.0 | 127.9 | 148.2 | |||||||||||||||||||||
| Total Assets | 412.9 | 343.7 | 1,125.7 | 1,162.4 | |||||||||||||||||||||
| Account Payables | 26.7 | 27.8 | 39.2 | 69.8 | |||||||||||||||||||||
| Short Term Debt | 0.2 | 60.0 | 0.2 | 6.0 | |||||||||||||||||||||
| Deferred Revenue | 5.7 | 7.5 | - | - | |||||||||||||||||||||
| Other Current Liabilities | 22.1 | 30.7 | 87.8 | 68.1 | |||||||||||||||||||||
| Total Current Liabilities | 95.1 | 165.4 | 127.1 | 143.9 | |||||||||||||||||||||
| Long Term Debt | 166.1 | 319.2 | 378.8 | 381.4 | |||||||||||||||||||||
| Other Non-Current Liabilities | 2,252.2 | 2,319.1 | 42.4 | 0.1 | |||||||||||||||||||||
| Total Non-Current Liabilities | 2,462.7 | 2,677.1 | 421.2 | 425.0 | |||||||||||||||||||||
| Total Liabilities | 2,557.9 | 2,842.6 | 548.4 | 568.9 | |||||||||||||||||||||
| Common Stock | 0.0 | 0.0 | 0.3 | 0.3 | |||||||||||||||||||||
| Retained Earnings | -2,119.2 | -2,472.3 | -2,548.7 | -2,549.2 | |||||||||||||||||||||
| Total Stockholders Equity | -2,145.0 | -2,498.8 | 577.3 | 593.5 | |||||||||||||||||||||
| Total Liabilities and Equity | 412.9 | 343.7 | 1,125.7 | 1,162.4 | |||||||||||||||||||||